rs1555225874

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_014254.3(RXYLT1):​c.146C>G​(p.Pro49Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000719 in 1,391,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

RXYLT1
NM_014254.3 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0930

Publications

0 publications found
Variant links:
Genes affected
RXYLT1 (HGNC:13530): (ribitol xylosyltransferase 1) This gene encodes a type II transmembrane protein that is thought to have glycosyltransferase function. Mutations in this gene result in cobblestone lissencephaly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
RXYLT1 Gene-Disease associations (from GenCC):
  • muscle-eye-brain disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05331251).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RXYLT1NM_014254.3 linkc.146C>G p.Pro49Arg missense_variant Exon 1 of 6 ENST00000261234.11 NP_055069.1 Q9Y2B1
RXYLT1XM_047428079.1 linkc.146C>G p.Pro49Arg missense_variant Exon 1 of 5 XP_047284035.1
RXYLT1NM_001278237.2 linkc.-968C>G 5_prime_UTR_variant Exon 1 of 6 NP_001265166.1 Q9Y2B1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RXYLT1ENST00000261234.11 linkc.146C>G p.Pro49Arg missense_variant Exon 1 of 6 1 NM_014254.3 ENSP00000261234.6 Q9Y2B1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.19e-7
AC:
1
AN:
1391530
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
688274
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30706
American (AMR)
AF:
0.0000283
AC:
1
AN:
35320
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24412
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80422
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38776
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5612
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1082266
Other (OTH)
AF:
0.00
AC:
0
AN:
57848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Sep 11, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces proline with arginine at codon 49 of the TMEM5 protein (p.Pro49Arg). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and arginine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with TMEM5-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
11
DANN
Benign
0.87
DEOGEN2
Benign
0.0022
T
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.38
T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.053
T
MetaSVM
Benign
-0.99
T
PhyloP100
0.093
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.48
N
REVEL
Benign
0.022
Sift
Benign
0.57
T
Sift4G
Benign
0.64
T
Polyphen
0.078
B
Vest4
0.12
MutPred
0.32
Gain of methylation at P49 (P = 0.0082);
MVP
0.13
MPC
1.2
ClinPred
0.074
T
GERP RS
0.26
PromoterAI
0.012
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.031
gMVP
0.51
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555225874; hg19: chr12-64173886; API